Milestone Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.21%38.350.9%$1232.83m
JNJJohnson & Johnson 0.00%147.550.7%$886.08m
MRKMerck & Co., Inc. -1.09%80.170.6%$632.23m
BMYBristol-Myers Squibb Co. -0.08%61.281.0%$601.55m
ABBVAbbVie, Inc. 0.20%92.751.9%$600.45m
AZNAstraZeneca Plc -1.17%55.551.2%$571.97m
LLYEli Lilly & Co. -0.63%151.911.1%$432.65m
NVSNovartis AG -0.73%82.800.2%$138.59m
OPKOPKO Health, Inc. 1.59%5.7511.2%$137.90m
GSKGlaxoSmithKline Plc -0.57%40.740.2%$135.42m
MISTMilestone Pharmaceuticals, Inc. 2.05%8.980.0%$122.14m
RGENRepligen Corp. 0.61%155.627.1%$69.65m
NVONovo Nordisk A/S 0.55%64.040.1%$66.24m
PRNBPrincipia Biopharma, Inc. 5.77%92.280.0%$62.27m
IMRNImmuron Ltd. 2.48%11.420.0%$55.23m

Company Profile

Milestone Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercialization of novel small molecule therapeutics based on clinically-validated mechanisms for the treatment of cardiovascular diseases. The firm designs and develops a rapid-onset nasal spray with Etripamil. The company was founded by Philippe Douville and Philippe Lamarre in 2005 and is headquartered in Montreal, Canada.